310.1 Improved pancreatic islet isolation yield after abdominal normothermic regional perfusion of controlled donation after circulatory death donors
Mr. Rutger M van Rooden, Netherlands
310.2 Islet Isolations From Extended Criteria Donors
Mr. Alan P Timpson, United Kingdom
310.3 Islet Transplantation using Donors After Brain and Cardiac Death: A Multicenter Clinical Trial in Japan
Dr. Takayuki Anazawa, Japan
310.4 Developing an algorithm for islet transplant dosing that considers both pancreas donor and islet recipient factors
Mr. Jared MR Firth, United Kingdom
310.5 10-year experience of Donors after Circulatory Death for Islet Transplantation in Scotland
Mr. Kenneth Nicoll, United Kingdom
310.6 Analysis of islet isolation from DCD for allogeneic human islet transplantation to type1 diabetes – single center experience.
Dr. Gumpei Yoshimatsu, Japan
310.7 Single nucleotide polymorphisms associated with human islet insulin secretion
Dr. Anjali Verma, United States
310.8 Naturally purified islets in total pancreatectomy (TP) and islet autotransplant (IAT) for chronic pancreatitis: a model to evaluate impact of exocrine co-transplant on graft function
Siri Larsen, United States
310.9 Hypoxia-related genes in pre-transplant human islets as potential markers for the transplantation outcomes in diabetic mice